All Stories

  1. Medicines registration requirements during the COVID-19 pandemic

    Article • Clinical Therapeutics, January 2021, Elsevier

    Thomas Kuhler

  2. How to optimize the development of rare disease medicines for children in the EU

    Article • Clinical Therapeutics, November 2019, Elsevier

    Thomas Kuhler, Hans Hoogland

  3. To what extent are review outcomes between the EMA and the US FDA aligned

    Article • BMJ Open, November 2019, BMJ

    Thomas Kuhler